SLOT: Full Definition
What is hormone replacement therapy?
Hormone replacement therapy — abbreviated HRT and increasingly called MHT (menopausal hormone therapy) — is the use of estrogen, progesterone, and sometimes testosterone to replace hormones that decline during Perimenopause and Menopause. The goal is to relieve symptoms, protect long-term health (bone, brain, cardiovascular, urogenital), and restore quality of life.
Modern HRT looks very different from the HRT that fell out of favor in the early 2000s — both in the molecules used and the way it is prescribed. Most prescriptions today rely on bioidentical estradiol (transdermal: patch, gel, or cream) paired with bioidentical oral micronized progesterone, with testosterone added when indicated.
Why HRT matters — the WHI reframe
In 2002, the Women's Health Initiative (WHI) trial paused early after reporting an increased risk of breast cancer and cardiovascular events in women on HRT. Within months, prescriptions plummeted. A generation of women was told HRT was unsafe.
In the years since, careful reanalysis has substantially changed that picture:
- The WHI used conjugated equine estrogens (Premarin) and medroxyprogesterone acetate (Provera) — older synthetic formulations, not the bioidentical estradiol and progesterone used today (see Bioidentical Vs Synthetic Hormones).
- The average participant was 63 years old — well past menopause. The risks identified do not apply the same way to women starting HRT in their 40s or early 50s, near the time of menopause (the "timing hypothesis" or "window of opportunity").
- The breast cancer signal was driven primarily by the synthetic progestin, not estrogen alone. Bioidentical progesterone does not appear to carry the same risk.
- Transdermal estradiol avoids the first-pass liver metabolism that drives clotting risk with oral estrogens.
Major menopause societies have since updated their guidance: for healthy women under 60 or within 10 years of menopause, the benefits of HRT for symptom relief, bone protection, and quality of life outweigh the risks for most. The narrative "HRT causes breast cancer" was never the full story, and the consequences of that misreading — millions of women left untreated through midlife — are now being corrected.
How MTC applies HRT
At Modern Thyroid Clinic, HRT decisions are individualized, evidence-informed, and conservative — but no longer fear-driven.
The typical approach:
- Comprehensive evaluation — symptoms, medical history, family history, baseline labs (sex hormones, thyroid, metabolic markers), and a Dutch Test when useful for understanding Estrogen Metabolism
- Bioidentical formulations by default — transdermal estradiol plus oral micronized progesterone; testosterone when indicated (see Testosterone Therapy Women)
- Multiple delivery options — patch, gel, cream, or Hormone Pellet Insertion; choice based on lifestyle and symptom pattern
- Lowest effective dose — titrated to symptoms, not a fixed protocol
- Parallel root-cause work — gut health, Hpa Axis, thyroid optimization, sleep, blood sugar, estrogen clearance
- Honest contraindications — active hormone-sensitive cancers, recent thrombotic events, and certain liver conditions remain absolute or relative contraindications
HRT is not for every woman, and it is not the whole answer for any woman. But for the right candidate, modern HRT is one of the most quality-of-life-changing interventions in women's medicine — restoring sleep, mood, libido, brain clarity, joint comfort, and skin and vaginal tissue health, while protecting bone and possibly brain and heart over the long arc.
Common symptoms
Common questions
Is HRT safe after the WHI study?
For most healthy women under 60 or within 10 years of menopause, modern HRT — particularly transdermal estradiol with oral micronized progesterone — is considered safe and beneficial by current menopause society guidelines. The WHI used older synthetic formulations in an older population, and reanalysis has shown the original risk reporting did not apply uniformly. That said, HRT is individualized: history of hormone-sensitive cancer, recent blood clots, and certain liver conditions remain contraindications. At Modern Thyroid Clinic, decisions are made collaboratively, with full discussion of benefits, risks, and alternatives.
When should I start HRT?
The strongest evidence supports starting HRT during [perimenopause] or within ten years of menopause — sometimes called the "window of opportunity." Starting earlier in this window offers more symptom relief and likely greater long-term cardiovascular and bone benefit than starting later. That does not mean HRT is unavailable to women starting later, but the risk-benefit balance shifts somewhat. The honest answer for most women is: if perimenopausal symptoms are affecting quality of life, that is the time to have the conversation, not years after.
What is the difference between HRT and birth control?
HRT uses physiologic doses of bioidentical hormones to gently restore what perimenopause and menopause take away. Birth control uses much higher, synthetic doses to suppress ovulation. They are not interchangeable. Some women in [perimenopause] are placed on birth control to manage symptoms; this can work, but for many women a lower-dose HRT approach with [bioidentical-vs-synthetic-hormones] formulations is better tolerated and more aligned with physiology. The right choice depends on age, contraceptive needs, and individual symptoms.
Think you might be dealing with this?
Talk to a Modern Thyroid Clinic specialist about your symptoms, labs, and next steps.
Book a Discovery CallThis content is for educational purposes only and is not medical advice. Consult a licensed clinician for diagnosis and treatment. Content on this page does not create a doctor-patient relationship with Modern Thyroid Clinic.